• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconGlaxoSmithKline

GlaxoSmithKline

ConferencesQueens of influence: Meet the women shaping Europe’s future
By Fortune EditorsMay 23, 2025
Emma Walmsley, chief executive officer of GSK Plc, following a Bloomberg Television interview in London, UK, on Tuesday, July 16, 2024. The threat of superbugs is not sufficiently understood, Walmsley said.
LeadershipGSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt
By Ryan HoggApril 2, 2025
Tech‘I’m not trying to turn GSK into Google’: How GSK’s Silicon Valley veteran has transformed the pharma giant into a tech powerhouse
By Ryan HoggMarch 25, 2025
Emma Walmsley, chief executive officer of GlaxoSmithKline speaks during the Clinton Global Initiative annual meeting in New York City on September 24, 2024.
HealthGSK could double CEO Emma Walmsley’s pay to $27 million in bid to bring U.K. exec salaries in line with the U.S.
By Ryan HoggFebruary 28, 2025
FinanceGSK reports fall in profit over Zantac fallout—but boosts 2031 revenue target to £40 billion due to boom in cancer drug sales
By AFPFebruary 5, 2025
RetailBritish pharma giant GSK to acquire U.S. drug developer IDRx in $1.15 billion deal
By AFPJanuary 14, 2025
A white sign featuring the Pfizer logo
HealthGSK, Pfizer RSV shots must warn about rare paralysis risk
By BloombergJanuary 8, 2025
As you dive into your New Year’s resolutions, taking precautions to protect yourself from a quartet of infectious diseases can lessen your odds of starting off 2025 sick.
HealthPublic health experts are warning of a ‘quad-demic’ this winter. Here’s where flu, COVID, RSV, and norovirus are spreading
By Lindsey LeakeDecember 18, 2024
RetailBritish pharma giant GSK reports a Q3 loss due to Zantac cancer lawsuits—but CEO Emma Walmsley remains optimistic on delivering 2024 guidance
By AFPOctober 30, 2024
RetailBritish pharma giant GSK strikes $2.3 billion deal to put an end to 80,000 U.S. lawsuits
By AFPOctober 10, 2024
As of spring 2024, at which time two RSV vaccines had been FDA-approved, less than 25% of eligible U.S. adults 60 and older had gotten one, according to the CDC.
HealthRSV can be deadly, especially for older adults. What to know about symptoms and the new vaccine
By Lindsey LeakeOctober 4, 2024
Photo of Anne Wojcicki
SuccessEvery single member of the board just resigned from DNA tester 23andMe
By Jane ThierSeptember 18, 2024
Zantac heartburn medicine are seen at a store in Mountain View, California
RetailVictory for drugmakers GSK and Boehringer in $640 million Zantac cancer lawsuit, but thousands still to come
By Jef Feeley, Ashleigh Furlong and BloombergMay 24, 2024
Emma Walmsley attends the 10th Annual Breakthrough Prize Awards and Ceremony at the Academy Museum of Motion Pictures in Los Angeles, California, United States
HealthHow GSK CEO Emma Walmsley kept her job and turned a belligerent activist investor into an ally
By Ashleigh Furlong, Sabah Meddings and BloombergMay 21, 2024
Aerial view of the City of London skyscrapers at night
FinanceLondon share sales have hit $11.3 billion for the year to date—despite an IPO drought, that’s still three times more than Paris
By Joe Easton and BloombergMay 20, 2024
1
  • 1
  • 2
  • 3
  • 4
  • 5
5
Most Popular
Success
After decades in the music industry, Pharrell Williams admits he never stops working: ‘If you do what you love everyday, you’ll get paid for free'An image of a popular article
By Emma BurleighFebruary 3, 2026
Politics
Peter Thiel warns the Antichrist and apocalypse are linked to the ‘end of modernity’ currently happening—and cites Greta Thunberg as a driving exampleAn image of a popular article
By Nick LichtenbergFebruary 4, 2026
Investing
Ray Dalio warns the world is ‘on the brink’ of a capital war of weaponizing money—and gold is the best way for people to protect themselvesAn image of a popular article
By Sasha RogelbergFebruary 4, 2026
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.